Transform Wealth, LLC Abb Vie Inc. Transaction History

Transform Wealth, LLC

$1.6 Billion
Q1 2025

A detailed history of Transform Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Transform Wealth, LLC holds 90,628 shares of ABBV stock, worth $19.8 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares

90,628

Previous 94,366 3.96%

Holding current value

$19.8 Million

Previous $16.8 Million 13.24%

% of portfolio

1.19%

Previous 0.96%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	SELL	$169.2 - $216.66 $632,469 - $809,875	-3,738 Reduced 3.96%	90,628 $19 Million
Q4 2024 Jan 16, 2025	BUY	$164.99 - $203.87 $1.16 Million - $1.44 Million	7,060 Added 8.09%	94,366 $16.8 Million
Q3 2024 Oct 15, 2024	BUY	$163.84 - $199.33 $191,037 - $232,418	1,166 Added 1.35%	87,306 $17.2 Million
Q2 2024 Jul 15, 2024	BUY	$154.79 - $180.76 $132,809 - $155,092	858 Added 1.01%	86,140 $14.8 Million
Q1 2024 Apr 15, 2024	SELL	$159.82 - $182.1 $78,471 - $89,411	-491 Reduced 0.57%	85,282 $15.5 Million
Q4 2023 Jan 18, 2024	SELL	$137.6 - $154.97 $1.98 Million - $2.23 Million	-14,385 Reduced 14.36%	85,773 $13.3 Million
Q3 2023 Oct 10, 2023	SELL	$133.59 - $154.65 $2.7 Million - $3.12 Million	-20,203 Reduced 16.79%	100,158 $14.9 Million
Q2 2023 Jul 13, 2023	BUY	$132.51 - $164.9 $59,496 - $74,040	449 Added 0.37%	120,361 $16.2 Million
Q1 2023 Apr 14, 2023	BUY	$144.61 - $166.54 $1,156 - $1,332	8 Added 0.01%	119,912 $19.1 Million
Q4 2022 Jan 12, 2023	BUY	$138.31 - $165.87 $18,395 - $22,060	133 Added 0.11%	119,904 $0
Q3 2022 Oct 21, 2022	BUY	$134.21 - $153.93 $77,170 - $88,509	575 Added 0.48%	119,771 $16.1 Million
Q2 2022 Jul 15, 2022	SELL	$137.62 - $174.96 $685,898 - $872,000	-4,984 Reduced 4.01%	119,196 $18.3 Million
Q1 2022 Apr 25, 2022	SELL	$131.98 - $163.75 $1.12 Million - $1.39 Million	-8,500 Reduced 6.41%	124,180 $20.1 Million
Q4 2021 Jan 26, 2022	SELL	$107.43 - $135.93 $66,606 - $84,276	-620 Reduced 0.47%	132,680 $18 Million
Q3 2021 Oct 15, 2021	BUY	$106.4 - $120.78 $233,654 - $265,232	2,196 Added 1.68%	133,300 $14.4 Million
Q2 2021 Jul 20, 2021	BUY	$105.21 - $117.21 $6.2 Million - $6.91 Million	58,936 Added 81.67%	131,104 $14.8 Million
Q1 2021 Apr 22, 2021	SELL	$102.3 - $112.62 $145,777 - $160,483	-1,425 Reduced 1.94%	72,168 $7.81 Million
Q4 2020 Jan 20, 2021	SELL	$80.49 - $108.67 $4.75 Million - $6.41 Million	-58,959 Reduced 44.48%	73,593 $7.89 Million
Q3 2020 Oct 21, 2020	BUY	$85.91 - $100.83 $429,292 - $503,847	4,997 Added 3.92%	132,552 $11.6 Million
Q2 2020 Jul 22, 2020	BUY	$73.37 - $98.18 $4.18 Million - $5.6 Million	57,003 Added 80.8%	127,555 $12.5 Million
Q1 2020 Apr 30, 2020	BUY	$64.5 - $97.79 $540,058 - $818,795	8,373 Added 13.47%	70,552 $5.38 Million
Q4 2019 Jan 24, 2020	BUY	$72.13 - $90.25 $284,769 - $356,307	3,948 Added 6.78%	62,179 $5.51 Million
Q3 2019 Oct 24, 2019	SELL	$62.98 - $75.72 $201,724 - $242,531	-3,203 Reduced 5.21%	58,231 $4.41 Million
Q2 2019 Jul 30, 2019	SELL	$65.7 - $83.98 $29,499 - $37,707	-449 Reduced 0.73%	61,434 $4.47 Million
Q1 2019 Apr 12, 2019	SELL	$77.14 - $90.79 $480,736 - $565,803	-6,232 Reduced 9.15%	61,883 $4.99 Million
Q4 2018 Jan 30, 2019	SELL	$77.85 - $96.01 $80,574 - $99,370	-1,035 Reduced 1.5%	68,115 $6.28 Million
Q3 2018 Oct 25, 2018	SELL	$88.91 - $98.84 $943,335 - $1.05 Million	-10,610 Reduced 13.3%	69,150 $6.54 Million
Q2 2018 Aug 03, 2018	BUY	$89.78 - $106.23 $363,519 - $430,125	4,049 Added 5.35%	79,760 $7.39 Million
Q1 2018 May 03, 2018	BUY	$92.01 - $123.21 $688,326 - $921,734	7,481 Added 10.96%	75,711 $7.17 Million
Q4 2017 Feb 08, 2018	BUY	$89.56 - $98.21 $2.89 Million - $3.17 Million	32,312 Added 89.96%	68,230 $6.6 Million
Q3 2017 Oct 19, 2017	BUY	$69.85 - $89.22 $2.51 Million - $3.2 Million	35,918	35,918 $3.19 Million

Others Institutions Holding ABBV

# of Institutions

4,382

Shares Held

1.3B

Call Options Held

16.1M

Put Options Held

10.9M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $386B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Transform Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transform Wealth, LLC with notifications on news.

Account

Transform Wealth, LLC Abb Vie Inc. Transaction History